Expertise in the CDISC ODM.  

Expertise in the CDISC ODM.

Assero Limited

  Home
  About Us

  ODM Compliance
  ODM Tools
  Consultancy
  Training

  Resources

  Contact Us

 

Home



Pharmaceutical and biotechnology companies are under increasing pressure to improve the speed of drug development. The figures are well known; the average cost to develop a drug to the post approval stage is reported by the Tufts Centre to be $890 million.

The introduction of technology has been one way in which companies have tried to improve their clinical trial processes. However, the move to replace paper with eClinical technologies has brought new challenges, the challenges that you face every day.

Assero are committed to helping pharmaceutical companies in the adoption of data interchange standards, focusing on the Clincial Data Interchange Standards Consortium (CDISC) Operational Data Model (ODM). Assero develop tools to assist companies comply with the standard and also help deploy the model in conjunction with the other CDISC models as part of the true eClinical trial. The company is a member of CDISC and actively supports the standards body in its activities, both in Europe and globally.

Use the menu to the left to find out more....

CDISC
Assero Limited
A CDISC Registered Solutions Provider


Recent Events:

Current e-Source Acceptance

DIA Euro Meeting 2008. Barcelona. March 3-5, 2008.

The Ever Expanding Role of the ODM

DIA 16th Annual CDM Conference.. Basel, Switzerland. November 5-8, 2006.

Published Articles:

The CDISC Operational Data Model: Ready To Roll?

Applied Clinical Trials. July 2004. Read it here.




    Privacy Policy
Home | Compliance | Tools | Consultancy | Training | Resources | Contact Us

Last Update: 21st November 2007 (R23.0.0)
© Assero Limited: 2003, 2004, 2005, 2006 & 2007